Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Diagnosis and Treatment of Pediatric Acute Neurologic Syndrome with Antineuronal Antibodies
Case ID:
TAB-3680
Web Published:
12/6/2022
The invention is a panel of five tests of patient sera for immune responses that may attack the brain and lead to the characteristic symptoms of pediatric acute neurologic syndrome (PANS). PANS is a condition defined by a sudden onset of obsessive-compulsive symptoms, eating restrictions, and other cognitive and/or behavioral symptoms. Currently, the diagnosis of PANS is made when other possible symptoms are ruled out, a diagnosis of exclusion.
The panel of tests in this invention provides a basis for the diagnosis and treatment of PANS in the setting of symptoms such as obsessions and compulsions, tics, autistic-like behaviors, anorexia nervosa, and deterioration in handwriting. The elevation above the normal mean or range of antibody titers in one or more of these assays indicates that the individual may be a candidate for treatment for PANS, including antibiotic therapy in the case of known infection, and also immunotherapy to treat the autoimmune/inflammatory condition of the brain.
Patent Information:
Title
App Type
Country
Serial No.
Patent No.
File Date
Issued Date
Expire Date
Direct Link:
https://canberra-ip.technologypublisher.com/tech/Diagnosis_and_Treatment_of_P ediatric_Acute_Neurologic_Syndrome_with_Antineuronal_Antibodies
Keywords:
ACUTE
antibodies
Antineuronal
Diagnosis
Listed LPM Greene as of 4/15/2015
Neurologic
pediatric
Post LPM Assignment Set 20150420
Pre LPM working set 20150418
Syndrome
treatment
VEXXXX
VNXXXX
WBXXXX
WIXXXX
XAXXXX
XCXXXX
Bookmark this page
Download as PDF
For Information, Contact:
Jennifer Wong
Technology Development Coordinator
NIH Technology Transfer
301-828-3707
jennifer.wong2@nih.gov